Preparation method of 8-bromo-2-oxo-1, 2-dihydroquinoxaline-6-carboxylic acid derivative
By using p-amino-N,N-dimethylbenzamide as a starting material and employing a series of defined steps of nitration, bromination, and cyclization reactions, the problems of difficult-to-obtain raw materials and high costs in existing technologies have been solved, and the preparation of 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives with high yields has been achieved, making it suitable for industrial production.
Patent Information
- Application Number
- CN202310505224.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-06
- Publication Date
- 2024-11-08
AI Technical Summary
Existing methods for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives suffer from problems such as difficulty in obtaining starting materials, high cost, low yield, and separation difficulties. In particular, when using 6-bromophenylenediamine derivatives and methyl 4-nitro-3-fluoro-5-bromobenzoate as raw materials, the synthesis is difficult and expensive, which is not conducive to industrial production.
Using p-amino-N,N-dimethylbenzamide as the starting material, a series of defined steps involving nitration, bromination, reduction, and cyclization reactions, including the use of specific solvents and post-treatment methods, were employed to achieve a highly selective and high-yield synthesis.
This method reduces raw material costs, increases reaction yield, and simplifies the operation process, making it suitable for industrial production.
Smart Images

Figure SMS_1 
Figure FDA0004219861810000021
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of chemical synthesis, and specifically relates to a method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives. Background Art
[0002] 8-Bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives are one of the hot research structures. For example, US5721248 discloses that quinoxaline derivatives substituted at the 8- and 2-positions have therapeutic effects on cardiovascular diseases. CN101678020 and Bioorganic & Medicinal Chemistry Letters report that quinoxaline compounds substituted at the 2- and 8-positions of the quinoxaline ring by cyclic groups can be used as inhibitors of the tyrosine kinase activity of Janus kinases including JAK-2 and JAK-3 kinases. CN113874380 reports that they have inhibitory activity against the replication of respiratory syncytial virus (RSV). It can be seen that 8-bromo-1H-quinoxaline-2-onecarboxylic acid derivatives have good biological activity. For example, they have a bromine reaction active point at the 8-position in their structure, which is easy to undergo substitution and coupling reactions, and they have a ketone functional group at the 2-position, which can undergo a variety of derivatization reactions. Therefore, 8-bromo-1H-quinoxaline-2-onecarboxylic acid derivatives are a class of common intermediates that are easy to prepare inhibitors of cardiovascular diseases, tyrosine kinase activity of Janus kinase, etc.
[0003] At present, the preparation methods of 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives are mainly the following two types: 1) such as WO 2018 / 178280 A1 and WO2008148867, using 6-bromophenylenediamine derivatives as raw materials and synthesizing through a series of reactions, two isomers will be produced in this route, resulting in difficulty in separating the products and low yields, and the starting raw material 6-bromophenylenediamine derivatives are difficult to prepare and expensive, so the cost is also high, which is not conducive to industrial production; 2) such as WO2018 / 178280A1, using 4-nitro-3-fluoro-5-bromo-benzoic acid methyl ester as raw material, the raw material 4-nitro-3-fluoro-5-bromo-benzoic acid methyl ester is difficult to synthesize, difficult and costly, and the substituted bromine will compete with fluorine. Summary of the invention
[0004] In view of the above problems existing in the prior art, the object of the present invention is to provide a method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives, which uses cheap and readily available p-amino-N,N-dimethylbenzamide as a starting material to synthesize 8-bromo-1H-quinoxaline-2-onecarboxylic acid derivatives, has a simple reaction process, is easy to operate and is easy to industrialize.
[0005] The present invention provides a method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives, which specifically comprises the following steps:
[0006] 1) dissolving p-amino-N,N-dimethylbenzamide as shown in formula (1) in acetic acid, reacting at 65-75°C for 3.5-4.5h, cooling to room temperature (25-35°C) after the reaction, slowly dropping concentrated nitric acid, stirring for 0.5h, then heating, reacting at 15-20°C for 12h, controlling the temperature to 0-5°C, slowly dropping 5% sodium carbonate aqueous solution, filtering after a large amount of solid precipitates, washing, filtering, and drying to obtain a yellow solid compound as shown in formula (2) 4-acetylamino-N,N-dimethyl-5-nitrobenzamide;
[0007] 2) dissolving the 4-acetylamino-N,N-dimethyl-5-nitrobenzamide shown in formula (2) obtained in step 1) in solvent A, adding bromine dropwise and reacting at 75-85° C. for 5-7 hours, and after the reaction, post-treating to obtain a light yellow solid 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide shown in formula (3);
[0008] 3) dissolving the 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide shown in formula (3) obtained in step 2) in solvent B, adding chloroacetyl chloride dropwise under stirring, heating and refluxing for reaction, and after the reaction, post-treating to obtain a white solid 4-chloroacetylamino-3-bromo-N,N-dimethyl-5-nitrobenzamide shown in formula (4);
[0009] 4) dissolving the 4-chloroacetylamino-3-bromo-N,N-dimethyl-5-nitrobenzamide obtained in step 3) as shown in formula (4) in solvent C, cooling to -5 to 0°C, adding stannous chloride, then slowly heating to 60 to 70°C for reaction for 2 to 4 hours, then heating to reflux for reaction, tracking the end of the reaction by TLC, and post-treating to obtain 8-bromo-N,N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide as shown in formula (5);
[0010] 5) adding 8-bromo-N,N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide as shown in formula (5) obtained in step 4) into solvent D to dissolve, cooling to 0-5° C., slowly adding manganese dioxide, heating to reflux for reaction, tracking the end of the reaction by TLC, and post-treating to obtain 8-bromo-N,N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid as shown in formula (6);
[0011] 6) dissolving the 8-bromo-N,N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid obtained in step 5) in alcohol, cooling to -5 to 0°C, adding thionyl chloride dropwise, heating to 15 to 30°C, reacting for 12 hours, tracking the end of the reaction by TLC, and passing through a column to obtain 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylate as shown in formula (7), wherein the alcohol is methanol, ethanol or benzyl alcohol;
[0012] The reaction process is as follows:
[0013]
[0014] Furthermore, the present invention also defines that the solvent A in step 2) is acetonitrile.
[0015] Furthermore, the present invention also defines the post-treatment process in step 2) as follows: after the reaction solution is cooled, an aqueous sodium sulfite solution is added for extraction, and then the acetonitrile is removed by concentration under reduced pressure, and the precipitated solid is filtered and dried to obtain a light yellow solid such as 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide as shown in formula (3).
[0016] Furthermore, the present invention also defines that the solvent B in step 3) is dichloromethane or dichloroethane, preferably dichloromethane.
[0017] Furthermore, the present invention also defines the post-treatment process in step 3) as follows: the reaction solution is cooled to room temperature, water is added for extraction, the liquid is separated, the organic phase is dried over anhydrous magnesium sulfate and then concentrated under reduced pressure, tertiary methyl ether is added for pulping, filtered, and dried to obtain 4-chloroacetylamino-3-bromo-N,N-dimethyl-5-nitrobenzamide as shown in formula (4).
[0018] Furthermore, the present invention also defines that the solvent C in step 4) is toluene.
[0019] Furthermore, the present invention also defines the post-treatment process in step 4) as follows: after the reaction solution is cooled, a sodium bicarbonate aqueous solution is added to adjust the pH to neutral, the solvent C is concentrated after layering, and then tert-butyl methyl ether is added, heated, crystallized, cooled, filtered, and dried to obtain 8-bromo-N,N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide as shown in formula (5).
[0020] Furthermore, the present invention also defines that the solvent D in step 5) is dichloromethane.
[0021] Furthermore, the present invention also defines the post-treatment process in step 5) as follows: after the reaction solution is cooled, deionized water is added, the organic layer is concentrated after stratification, and then ethanol is added for recrystallization to obtain 8-bromo-N, N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxamide as shown in formula (6).
[0022] By adopting the above technology, compared with the prior art, the beneficial effects of the present invention are as follows:
[0023] 1) The present invention uses p-amino-N,N-dimethylbenzamide as a starting material, which has a simple source and is cheap, thus reducing the cost to a certain extent;
[0024] 2) The present invention adopts a limited method to carry out nitration reaction and bromination reaction, which has high reaction selectivity and high yield, and can improve economic benefits;
[0025] 3) The present invention adopts a one-pot synthesis in the reduction reaction and the cyclization reaction, which is simple to operate and greatly improves the yield. DETAILED DESCRIPTION
[0026] The present invention is further described below in conjunction with embodiments, but the protection scope of the present invention is not limited thereto:
[0027] Example 1: 8-Bromo-N,N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxamide
[0028] 1) dissolving p-amino-N,N-dimethylbenzamide (100 g, 0.610 mol) in 300 ml of acetic anhydride, reacting at 70° C. for 4 h, cooling to room temperature, slowly adding 200 ml of concentrated nitric acid, stirring for 0.5 h, heating, reacting at 15-20° C. for 12 h, controlling the temperature to about 0° C., slowly adding 5% sodium carbonate aqueous solution, filtering after a large amount of solid precipitated, washing with water three times, filtering and drying to obtain 4-acetylamino-N,N-dimethyl-5-nitrobenzamide (135.38 g, yield 88.4%) as a yellow solid compound represented by formula (2);
[0029] 2) 4-acetylamino-N,N-dimethyl-5-nitrobenzamide (100 g, 0.446 mol) as shown in formula (2) was dissolved in 300 ml of acetonitrile, bromine (85.71 g, 0.536 mol) was added dropwise, and the mixture was reacted at 80° C. for 6 h. After cooling, an aqueous sodium sulfite solution was added to extract and quench, and the acetonitrile was concentrated under reduced pressure to precipitate a solid, which was filtered and dried to obtain a light yellow solid compound as shown in formula (3) as 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide (100.92 g, yield 86.7%);
[0030] 3) 4-amino-3-bromo-N, N-dimethyl-5-nitrobenzamide (100 g, 0.383 mol) as shown in formula (3) was dissolved in 500 ml of dichloromethane, chloroacetyl chloride (40.86 g, 1.5 mol) was added dropwise, the temperature was raised to reflux temperature for reaction for 6 h, cooled to room temperature, 100 ml of water was added for extraction, the organic phase was separated, dried over anhydrous magnesium sulfate, concentrated under reduced pressure, 300 ml of tert-methyl ether was added for pulping, filtered and dried to obtain 4-chloroacetylamino-3-bromo-N, N-dimethyl-5-nitrobenzamide (123.78 g, yield 95.9%) as a white solid as shown in formula (4). 1H NMR(400MHz,DMSO-d6)δ10.68(s,1H),8.15(d,1H),8.04(d,1H),4.37(s,2H),2.94(s,3H),2.89(s,3H).HRMS(ESI)calcd for C11H11BrClN3O4[M+H]+:363.9700; Found:363.9698.
[0031] 4) 4-chloroacetylamino-3-bromo-N, N-dimethyl-5-nitrobenzamide (100 g, 0.297 mol) shown in formula (4) was dissolved in toluene, cooled to -5-0°C, added with stannous chloride (56.32 g, 0.297 mol) and then slowly heated to 60-70°C for reaction for 3 hours, and then heated under reflux until the reaction was complete as tracked by TLC, the reaction solution was cooled, and sodium bicarbonate aqueous solution was added to adjust the pH to neutral. After separation, toluene was concentrated, tert-butyl methyl ether was added, heated, crystallized, cooled, filtered, and dried to obtain 8-bromo-N, N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide (71.23 g, yield 88.5%) shown in formula (5). 1HNMR(400MHz,DMSO-d6)δ9.56(s,1H),6.74(d,1H),6.65(d,1H),4.28(s,2H),2.93(d,6H).HRMS(ESI)calcd for C11H12BrN3O2[M+H]+:298.0191; Found:298.0179.
[0032] 5) 8-bromo-N, N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide (100 g, 0.369 mol) shown in formula (5) was dissolved in 340 ml of dichloromethane, cooled to 0-5°C, and manganese dioxide (80.16 g, 0.923 mol) was slowly added, and the temperature was raised to reflux until the reaction was completed by TLC tracking, and sodium hydroxide was added to adjust the pH to 13, heated to reflux, and the reaction was completed by TLC tracking. The reaction solution was cooled, 100 ml of deionized water was added to separate the layers, and the pH value was adjusted to 2 with hydrochloric acid. The 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid (89.43 g, yield 90.1%) shown in formula (6) was obtained by cooling and crystallization. HRMS (ESI) calcd for C9H5BrN2O3[M+H]+: 283.0810; Found: 283.0792.
[0033] 6) Dissolve 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid (50 g, 0.186 mol) obtained in step 5) as shown in formula (6) in 200 ml of methanol, cool to -5 to 0°C, add thionyl chloride (24.35 g, 0.205 mol) dropwise, heat to 15 to 30°C and react for 12 hours. TLC tracks the end of the reaction, and column chromatography gives 1-7: 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid methyl ester. (48.32 g, yield 91.8%) HRMS (ESI) calcd for C10H7BrN2O3[M+H]+: 269.0540; Found: 269.0553.
[0034] Example 2: Ethyl 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylate
[0035] 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid (50 g, 0.186 mol) obtained in step 5) of Example 1 as shown in formula (6) was dissolved in 250 ml of ethanol, cooled to 0-5°C, thionyl chloride (23.20 g, 0.195 mol) was added dropwise, and the temperature was raised to 30-40°C for reaction for 8 hours. The reaction was completed by TLC tracking, and the compound 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid ethyl ester (48.32 g, yield 91.8%) as shown in formula (7) was obtained by column chromatography. HRMS (ESI) calcd for C11H9BrN2O3[M+H]+: 297.1080; Found: 297.1093.
[0036] Example 3: 8-Bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid benzyl ester
[0037] The 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid (50 g, 0.186 mol) obtained in step 5) of Example 1 as shown in formula (6) was dissolved in 300 ml of dichloromethane, cooled to 0-5°C, thionyl chloride (23.20 g, 0.195 mol) was added dropwise, the temperature was raised to 30-40°C, the reaction was continued for 8 hours, and the reaction was completed by TLC tracking. The mixture was cooled to -5-0°C, benzyl alcohol (24.10 g, 0.223 mol) was added dropwise, the temperature was raised to 30-40°C, the reaction was continued for 6 hours, the reaction was completed by TLC tracking, and the compound 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid benzyl ester (48.32 g, yield 86.2%) as shown in formula (7) was obtained. (57.72 g, yield 91.8%) HRMS (ESI) calcd for C16H11BrN2O3[M+H]+: 359.1790; Found: 359.1772.
Claims
1. A method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives, characterized in that The steps include: 1) dissolving p-amino-N,N-dimethylbenzamide as shown in formula (1) in acetic acid, reacting at 65-75° C. for 3.5-4.5 hours, cooling to room temperature after the reaction, slowly dropping concentrated nitric acid, stirring evenly and heating, reacting at 15-20° C., controlling the temperature to 0-5° C. after the reaction, slowly dropping 5% sodium carbonate aqueous solution, filtering after a large amount of solid precipitates, washing, filtering and drying to obtain a yellow solid compound as shown in formula (2) 4-acetylamino-N,N-dimethyl-5-nitrobenzamide; 2) dissolving the 4-acetylamino-N,N-dimethyl-5-nitrobenzamide shown in formula (2) obtained in step 1) in solvent A, adding bromine dropwise at 75-85° C. for 5-7 hours, and after the reaction, post-treating to obtain a light yellow solid 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide shown in formula (3); 3) dissolving the 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide shown in formula (3) obtained in step 2) in solvent B, adding chloroacetyl chloride dropwise under stirring, heating and refluxing for reaction, and after the reaction, post-treating to obtain a white solid 4-chloroacetylamino-3-bromo-N,N-dimethyl-5-nitrobenzamide shown in formula (4); 4) dissolving the 4-chloroacetylamino-3-bromo-N,N-dimethyl-5-nitrobenzamide obtained in step 3) as shown in formula (4) in solvent C, cooling to -5 to 0°C, adding stannous chloride, then slowly heating to 60 to 70°C for reaction for 2 to 4 hours, then heating to reflux for reaction, tracking the end of the reaction by TLC, and post-treating to obtain 8-bromo-N,N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide as shown in formula (5); 5) adding 8-bromo-N,N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide as shown in formula (5) obtained in step 4) into solvent D to dissolve, cooling to 0-5° C., slowly adding manganese dioxide, heating to reflux for reaction, tracking the end of the reaction by TLC, and post-treating to obtain 8-bromo-N,N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid as shown in formula (6); 6) dissolving the 8-bromo-N,N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid obtained in step 5) in alcohol, cooling to -5 to 0°C, adding thionyl chloride dropwise, heating to 15 to 30°C for reaction, tracking the end of the reaction by TLC, and passing through a column to obtain 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylate as shown in formula (7), wherein the alcohol is methanol, ethanol or benzyl alcohol; The reaction process is as follows:
2. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The solvent A in step 2) is acetonitrile.
3. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The post-treatment process in step 2) is as follows: after the reaction solution is cooled, an aqueous sodium sulfite solution is added to extract and quench, and then the acetonitrile is removed by vacuum concentration, and the precipitated solid is filtered and dried to obtain a light yellow solid such as 4-amino-3-bromo-N,N-dimethyl-5-nitrobenzamide as shown in formula (3).
4. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The solvent B in step 3) is dichloromethane or dichloroethane, preferably dichloromethane.
5. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The post-treatment process in step 3) is as follows: the reaction solution is cooled to room temperature, water is added to extract and quench, the liquid is separated, the organic phase is dried over anhydrous magnesium sulfate and then concentrated under reduced pressure, tertiary methyl ether is added for pulping, filtered and dried to obtain 4-chloroacetylamino-3-bromo-N,N-dimethyl-5-nitrobenzamide as shown in formula (4).
6. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The solvent C in step 4) is toluene.
7. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The post-treatment process in step 4) is as follows: after the reaction solution is cooled, a sodium bicarbonate aqueous solution is added to adjust the pH to neutral, after separation, the solvent C is concentrated, and then tert-butyl methyl ether is added to heat, crystallize, cool, filter, and dry to obtain 8-bromo-N,N-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide as shown in formula (5).
8. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The solvent D in step 5) is dichloromethane.
9. The method for preparing 8-bromo-2-oxo-1,2-dihydroquinoxaline-6-carboxylic acid derivatives according to claim 1, characterized in that The post-treatment process in step 5) is as follows: after the reaction solution is cooled, deionized water is added, the organic layer is concentrated after separation, and then ethanol is added for recrystallization to obtain 8-bromo-N, N-dimethyl-2-oxo-1,2-dihydroquinoxaline-6-carboxamide as shown in formula (6).
